These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 11856509)

  • 41. [Serum myoinositol and phosphatidylinositol in patients with viral hepatitis].
    Tkaczewski W; Tkacz B; Lutz W; Szeszko A; Dworniak D; Drobnik S
    Pol Tyg Lek; 1977 Dec; 32(49):1913-5. PubMed ID: 604964
    [No Abstract]   [Full Text] [Related]  

  • 42. [Clinical, biochemical, and morphological characteristics of chronic hepatitis with various etiology].
    Masevich TsG; Ermolaeva LG
    Ter Arkh; 2002; 74(2):35-7. PubMed ID: 11899821
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Monitoring liver function.
    Schoch L; Whiteman K
    Nursing; 2007 Nov; 37(11):22-3. PubMed ID: 17968248
    [No Abstract]   [Full Text] [Related]  

  • 44. [Study on the damage of liver in patients with SARS].
    Guan YJ; Tang XP; Yin CB; Yi ZQ
    Zhongguo Wei Zhong Bing Ji Jiu Yi Xue; 2004 May; 16(5):267-70. PubMed ID: 15132787
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Safety and efficacy of lamivudine in patients with severe acute or fulminant hepatitis B, a multicenter experience.
    Tillmann HL; Hadem J; Leifeld L; Zachou K; Canbay A; Eisenbach C; Graziadei I; Encke J; Schmidt H; Vogel W; Schneider A; Spengler U; Gerken G; Dalekos GN; Wedemeyer H; Manns MP
    J Viral Hepat; 2006 Apr; 13(4):256-63. PubMed ID: 16611192
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Real time monitoring of heparin anticoagulant therapy in severe hepatitis patients treated with plasma exchange].
    Chen Y; Duan ZP; Han DK; Zhao J; Li Y; Yang JK
    Zhonghua Gan Zang Bing Za Zhi; 2005 Jun; 13(6):465-6. PubMed ID: 15975290
    [No Abstract]   [Full Text] [Related]  

  • 47. Severe hepatitis treated with an artificial liver support system.
    Lanjuan L; Qian Y; Jianrong H; Xiaowei X; Yuemei C; Yagang C; Weihang M; Zhi C; Suzhen F
    Int J Artif Organs; 2001 May; 24(5):297-303. PubMed ID: 11420879
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Effects of prostaglandin E1 on hepatic function and hepatofibrosis in patients with chronic hepatitis B].
    Gong HY; Wang KQ; Tang SG; Zhang WJ
    Hunan Yi Ke Da Xue Xue Bao; 2001 Oct; 26(5):445-7. PubMed ID: 12536496
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Traditional kava beverage consumption and liver function tests in a predominantly Tongan population in Hawaii.
    Brown AC; Onopa J; Holck P; Kaufusi P; Kabasawa D; Craig WJ; Dragull K; Levine AM; Baker JD
    Clin Toxicol (Phila); 2007; 45(5):549-56. PubMed ID: 17503265
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Studies of serum folic acid level in patients with viral hepatitis.
    Tkaczewski W; Niedzielska H; Malafiej E; Dworniak D; Dramiński M
    Pol Med J; 1971; 10(5):1081-4. PubMed ID: 5133656
    [No Abstract]   [Full Text] [Related]  

  • 51. Use of steatotic graft in living-donor liver transplantation.
    Soejima Y; Shimada M; Suehiro T; Kishikawa K; Yoshizumi T; Hashimoto K; Minagawa R; Hiroshige S; Terashi T; Ninomiya M; Shiotani S; Harada N; Sugimachi K
    Transplantation; 2003 Jul; 76(2):344-8. PubMed ID: 12883190
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Hepatic alterations in patients with dengue].
    Larreal Y; Valero N; Estévez J; Reyes I; Maldonado M; Espina LM; Arias J; Meleán E; Añez G; Atencio R
    Invest Clin; 2005 Jun; 46(2):169-78. PubMed ID: 16001748
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Analysis of liver function in renal transplant recipients undergoing C2-monitoring for cyclosporine.
    Hecking M; Kainz A; Schillinger M; Posch C; Birsan T; Rasoul-Rockenschaub S; Böhmig GA; Schmaldienst S; Watschinger B; Hörl WH; Mühlbacher F; Säemann MD
    Transpl Int; 2008 Mar; 21(3):223-33. PubMed ID: 17903183
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Biochemical parameters of hepatobiliary system functions in viral hepatitis or ixodes tick-borne borreliosis concurrent with chronic opisthorchiasis].
    Bakshtanovskaia IV; Stepanova TF; Stepanova KB; Postnikova TF; Kolchanova LP
    Med Parazitol (Mosk); 2007; (4):12-6. PubMed ID: 18274146
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Changes of the serum protein picture in viral hepatitis. I. Evaluation of protein synthesis].
    Borsotti M; De Phillipis C; Leoncini F; Mazzota F; Milo D; Paci P; Piazza E; Spadolini MP
    Quad Sclavo Diagn; 1980 Dec; 16(4):368-84. PubMed ID: 7244110
    [No Abstract]   [Full Text] [Related]  

  • 56. Assessment of liver function in mice.
    Becker BA; Plaa GL
    Lab Anim Care; 1967 Jun; 17(3):267-72. PubMed ID: 4228078
    [No Abstract]   [Full Text] [Related]  

  • 57. A comparative study of regression of jaundice in patients of malaria and acute viral hepatitis.
    Kochar DK; Kaswan K; Kochar SK; Sirohi P; Pal M; Kochar A; Agrawal RP; Das A
    J Vector Borne Dis; 2006 Sep; 43(3):123-9. PubMed ID: 17024861
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Study of severe hepatitis treated with a hybrid artificial liver support system.
    Qian Y; Lanjuan L; Jianrong H; Jun L; Hongcui C; Suzhen F; Xia Y; Shuhong Y
    Int J Artif Organs; 2003 Jun; 26(6):507-13. PubMed ID: 12866656
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Metabolic effects of a novel bioartificial liver on serum from severe hepatitis patients: an in vitro study.
    Yan F; Zhao J; Ma J; Li Z; Su Q
    Chin Med J (Engl); 2003 Oct; 116(10):1471-4. PubMed ID: 14570603
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Outcome after liver re-transplantation in patients with recurrent chronic hepatitis C.
    Bahra M; Neumann UP; Jacob D; Berg T; Neuhaus R; Langrehr JM; Neuhaus P
    Transpl Int; 2007 Sep; 20(9):771-8. PubMed ID: 17617179
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.